Mass screening for neuroblastoma in infants.
Journal
Discovery medicine
ISSN: 1944-7930
Titre abrégé: Discov Med
Pays: United States
ID NLM: 101250006
Informations de publication
Date de publication:
Historique:
entrez:
31
12
2020
pubmed:
1
1
2021
medline:
28
9
2021
Statut:
ppublish
Résumé
Neuroblastoma (NB) is the only pediatric tumor that is screened for nationwide by detecting the urinary levels of homovanillic acid and/or vanillylmandelic acid; however, whether NB screening reduces the mortality rate has not been established. This review compared the incidence and mortality rates among data from international mass screening for NB, as well as an analysis of differences in age of screening, detection methods, and diagnostic biomarkers. A well-designed trial exploring possible benefits and hazards is warranted prior to resuming mass screening for NB.
Substances chimiques
Biomarkers, Tumor
0
Vanilmandelic Acid
55-10-7
Homovanillic Acid
X77S6GMS36
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM